# Amneal (AMRX) — Earnings

AMRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/amrx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.30 |
| EPS estimate | $0.22 |
| EPS surprise | +34.83% |
| Revenue surprise | +3.64% |
| Revenue | $796.2M |
| Revenue estimate | $768.2M |
| Reported | Jul 30, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1723128/000172312826000031/amrx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/eed54c66-94ff-b97b-d530-06b1030aec3c.html) |

Amneal reported Q2 2026 results on July 30, 2026. Earnings per share were $0.30, beating the $0.22 estimate by 34.83%. Revenue was $796.2 million, 3.64% above the $768.2 million consensus. Compared with Q2 2025, EPS rose 20% from $0.25 and revenue grew about 10% from $724.5 million.

Revenue has grown steadily over the table. Annual sales rose from about $2.21 billion in 2022 to $3.02 billion in 2025, an increase of about 37%, and Q4 2025 set the quarterly high at $814.3 million. Earnings were flatter for a time: annual EPS went from $0.68 in 2022 to $0.64 in 2023 and $0.58 in 2024, then rose about 45% to $0.84 in 2025. Q2 2026's $0.30 is the highest quarterly EPS shown. Amneal beat the EPS estimate in 16 of the last 20 quarters, including the last six in a row, and the table does not include a row for Q4 2021.

Amneal reported Q3 between October 30 and November 8 in each of the past five years. That points to late October or early November 2026 for the next report. It will show whether the year-over-year gains in earnings and revenue continue into the third quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Jul 30, 2026 | $0.22 | $0.30 | 34.83% | $768.2M | $796.2M |
| Q1 2026 | Apr 22, 2026 | $0.17 | $0.27 | 59.67% | $719.7M | $722.5M |
| Q4 2025 | Feb 27, 2026 | $0.18 | $0.21 | 14.07% | $807.4M | $814.3M |
| Q3 2025 | Oct 30, 2025 | $0.14 | $0.17 | 22.92% | $773.9M | $784.5M |
| Q2 2025 | Aug 5, 2025 | $0.18 | $0.25 | 42.86% | $744.6M | $724.5M |
| Q1 2025 | May 2, 2025 | $0.15 | $0.21 | 43.15% | $714.8M | $695.4M |
| Q4 2024 | Feb 28, 2025 | $0.15 | $0.12 | -21.31% | $708.1M | $730.5M |
| Q3 2024 | Nov 8, 2024 | $0.13 | $0.16 | 19.05% | $693.8M | $702.5M |
| Q2 2024 | Aug 9, 2024 | $0.15 | $0.16 | 8.47% | $657.5M | $701.8M |
| Q1 2024 | May 3, 2024 | $0.09 | $0.14 | 52.01% | $619.0M | $659.2M |
| Q4 2023 | Mar 1, 2024 | $0.09 | $0.14 | 55.21% | $635.0M | $617.0M |
| Q3 2023 | Nov 7, 2023 | $0.13 | $0.19 | 49.84% | $602.6M | $620.0M |
| Q2 2023 | Aug 4, 2023 | $0.10 | $0.19 | 91.92% | $565.1M | $599.0M |
| Q1 2023 | May 5, 2023 | $0.10 | $0.12 | 25.00% | $539.1M | $557.5M |
| Q4 2022 | Mar 2, 2023 | $0.21 | $0.23 | 10.52% | $579.8M | $609.8M |
| Q3 2022 | Nov 4, 2022 | $0.18 | $0.14 | -20.86% | $562.1M | $545.6M |
| Q2 2022 | Aug 5, 2022 | $0.19 | $0.19 | -2.26% | $534.5M | $559.4M |
| Q1 2022 | May 4, 2022 | $0.13 | $0.12 | -6.69% | $502.3M | $497.6M |
| Q3 2021 | Nov 3, 2021 | $0.20 | $0.21 | 2.79% | $544.1M | $528.6M |
| Q2 2021 | Aug 9, 2021 | $0.18 | $0.25 | 36.02% | $522.6M | $535.1M |

## Frequently Asked Questions

### When did Amneal (AMRX) last report earnings?

Amneal last reported on Jul 30, 2026, covering fiscal Q2 2026.

### Did AMRX beat earnings estimates?

Yes. Amneal reported EPS of $0.30 for Q2 2026 against a $0.22 estimate — a 34.83% beat.

### How much revenue did AMRX report last quarter?

Amneal reported $796.2M in revenue for Q2 2026, against a consensus estimate of $768.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).